Literature DB >> 25802341

The fallopian tube: from back stage to center stage.

Mark H Greene1, Phuong L Mai2.   

Abstract

The recognition that a significant fraction of what historically has been classified as ovarian cancer is, in fact, a malignancy that arises in the fallopian tube mucosa comprises a paradigm shift in our understanding of these neoplasms. New etiologic and management opportunities have been created by this insight, both for women at increased genetic risk of ovarian cancer by virtue of being BRCA1/2 mutation carriers and, perhaps, for women in the general population as well. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2015        PMID： 25802341      PMCID： PMC4417405          DOI： 10.1158/1940-6207.CAPR-15-0072

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


  24 in total

1.  Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.

Authors:  James R Conner; Emily Meserve; Ellen Pizer; Judy Garber; Michael Roh; Nicole Urban; Charles Drescher; Bradley J Quade; Michael Muto; Brooke E Howitt; Mark D Pearlman; Ross S Berkowitz; Neil Horowitz; Christopher P Crum; Colleen Feltmate
Journal:  Gynecol Oncol       Date:  2013-12-12       Impact factor: 5.482

2.  Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Authors:  Amy P M Finch; Jan Lubinski; Pål Møller; Christian F Singer; Beth Karlan; Leigha Senter; Barry Rosen; Lovise Maehle; Parviz Ghadirian; Cezary Cybulski; Tomasz Huzarski; Andrea Eisen; William D Foulkes; Charmaine Kim-Sing; Peter Ainsworth; Nadine Tung; Henry T Lynch; Susan Neuhausen; Kelly A Metcalfe; Islay Thompson; Joan Murphy; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2014-02-24       Impact factor: 44.544

3.  Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.

Authors:  Janice S Kwon; Jessica N McAlpine; Gillian E Hanley; Sarah J Finlayson; Trevor Cohen; Dianne M Miller; C Blake Gilks; David G Huntsman
Journal:  Obstet Gynecol       Date:  2015-02       Impact factor: 7.661

4.  A major step forward for BRCA1/2-related cancer risk management.

Authors:  Phuong L Mai; Jennifer T Loud; Mark H Greene
Journal:  J Clin Oncol       Date:  2014-03-31       Impact factor: 44.544

Review 5.  Salpingectomy as a means to reduce ovarian cancer risk.

Authors:  Mary B Daly; Charles W Dresher; Melinda S Yates; Joanne M Jeter; Beth Y Karlan; David S Alberts; Karen H Lu
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-13

6.  Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.

Authors:  Jessica N McAlpine; Gillian E Hanley; Michelle M M Woo; Alicia A Tone; Nirit Rozenberg; Kenneth D Swenerton; C Blake Gilks; Sarah J Finlayson; David G Huntsman; Dianne M Miller
Journal:  Am J Obstet Gynecol       Date:  2014-01-09       Impact factor: 8.661

7.  Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

Authors:  Mark H Greene; Phuong L Mai; Peter E Schwartz
Journal:  Am J Obstet Gynecol       Date:  2010-07-08       Impact factor: 8.661

8.  Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.

Authors:  Laura L Holman; Sue Friedman; Molly S Daniels; Charlotte C Sun; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-02-28       Impact factor: 5.482

9.  Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.

Authors:  P Tonin; R Moslehi; R Green; B Rosen; D Cole; N Boyd; C Cutler; R Margolese; R Carter; B McGillivray
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

10.  Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

Authors:  Mark E Sherman; Marion Piedmonte; Phuong L Mai; Olga B Ioffe; Brigitte M Ronnett; Linda Van Le; Iouri Ivanov; Maria C Bell; Stephanie V Blank; Paul DiSilvestro; Chad A Hamilton; Krishnansu S Tewari; Katie Wakeley; Noah D Kauff; S Diane Yamada; Gustavo Rodriguez; Steven J Skates; David S Alberts; Joan L Walker; Lori Minasian; Karen Lu; Mark H Greene
Journal:  J Clin Oncol       Date:  2014-09-08       Impact factor: 44.544
View more
  1 in total

1.  Bilateral Risk-Reducing Prophylactic Mastectomies in an Unaffected BRCA1 Carrier Using Dermal Sling and Implant.

Authors:  Sandhya Gupta; Geeta Kadayaprath; Neerja Gupta; Vipin Barthwal
Journal:  Indian J Surg Oncol       Date:  2021-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.